MedTrace Logo

Endurant Evo US Clinical Trial

NCT02393716 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 139

Last updated 2022-12-06

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to demonstrate that the Endurant Evo Abdominal Aortic Aneurysm (AAA) stent graft system is safe and effective for endovascular treatment of infrarenal abdominal aortic or aortoiliac aneurysms.

Conditions

  • Abdominal Aortic Aneurysm
  • AAA

Interventions

DEVICE

Endurant Evo AAA Stent Graft System

PROCEDURE

Endovascular aneurysm repair (EVAR)

Sponsors & Collaborators

  • Medtronic Cardiovascular

    lead INDUSTRY

Principal Investigators

  • Gilbert Upchurch, MD · University of Florida

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2021-06-25
Completion
2021-06-25
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02393716 on ClinicalTrials.gov